Bone mineral density in young women with long-standing amenorrhea: Limited effect of hormone replacement therapy with ethinylestradiol and desogestrel
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To assess bone mineral density (BMD) at different skeletal sites in women with hypothalamic or ovarian amenorrhea and the effect of estrogen-gestagen substitution on BMD we compared BMD of 21 amenorrheic patients with hypothalamic or ovarian amenorrhea with that of a control population of 123 healthy women. All amenorrheic patients were recruited from the outpatient clinic of the Division of Gynecological Endocrinology at the University of Berne, a public University Hospital. One hundred and twenty-three healthy, regularly menstruating women recruited in the Berne area served as a control group. BMD was measured using dual-energy X-ray absorptiometry (DXA). At each site where it was measured, mean BMD was lower in the amenorrheic group than in the control group. Compared with the control group, average BMD in the amenorrheic group was 85% at lumbar spine (p<0.0001), 92% at femoral neck (p<0.02), 90% at Ward's triangle (p<0.03), 92% at tibial diaphysis (p<0.0001) and 92% at tibial epiphysis (p<0.03). Fifteen amenorrheic women received estrogen-gestagen replacement therapy (0.03 mg ethinylestradiol and 0.15 mg desogestrel daily for 21 days per month), bone densitometry being repeated within 12–24 months. An annual increase in BMD of 0.2% to 2.9% was noted at all measured sites, the level of significance being reached at the lumbar spine (p<0.0012) and Ward's triangle (p<0.033). In conclusion BMD is lower in amenorrheic young women than in a population of normally menstruating, age-matched women in both mainly trabecular (lumbar spine, Ward's triangle, tibial epiphysis) and mainly cortical bone (femoral neck, tibial diaphysis). In these patients, hormone replacement therapy resulted in a limited recovery of BMD. Therefore, early hormone replacement therapy is mandatory for young amenorrheic women to minimize bone loss.
- Albright F, Blomberg E, Smith PA. Postmenopausal osteoporosis. Trans Assoc Am Physicians 1940;55:298–305.
- Lindsay R, Aitken JM, Anderson JN, Hart DM, MacDonald EB, Clark AC. Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet 1976;1:1038–41.
- Christiansen C, Christiansen MS, McNair P, Hagen C, Stocklund KE, Transböl IB. Prevention of early postmenopausal bone loss: controlled study in 315 normal females. Eur J Clin Invest 1980;10:273–99.
- Riggs BL, Melton LJ. Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 1983;75:899–901.
- Stevenson JC, Banks LM, Spinks TJ, et al. Regional and total skeletal measurements in the early postmenopause. J Clin Invest 1987;80:258–62.
- Riggs BL, Wahner HW, Melton LJ III, Judd HL, Offord K.P. Rates of bone loss in the appendicular and axial skeletons of women: evidence of substantial vertebral bone loss before menopause. J Clin Invest 1986,77:1487–91.
- Cann CE, Martin MC, Genant HK, Jaffe RB. Decreased spinal mineral content in amenorrheic women. JAMA 1984;251:626–9.
- Davies MC, Hall ML, Jacobs HS. Bone mineral loss in young women with amenorrhea. BMJ 1990;301:790–3.
- Metka M, Holzer G, Heytmanek G, Huber J. Hypergonadotropic hypogonadic amenorrhea (World Health Organization III) and osteoporosis. Fertil Steril 1992;57:37–41.
- Schlechte JA, Sherman B, Martin R. Bone density in amenorrhoic women with and without hyperprolactinemia. J Clin Endocrinol Metab 1983;56:1120–3.
- Rigotti NA, Nussbaum SR, Herzog DB, Neer RM. Osteoporosis in women with anorexia nervosa. N Engl J Med 1984;311:1601–6.
- Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR. The clinical course of osteoporosis in anorexia nervosa: a longitudinal study of cortical bone mass. JAMA 1991;265:1133–8.
- Drinkwater BL, Nilson K, Chesnut CH III, Bremner WJ, Shainholtz S, Southworth MB. Bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med 1984;11:277–81.
- Wolman RL, Clark P, McNally E, Harries M, Reeve J. Menstrual state and exercise as determinants of spinal trabecular bone density in female athletes. BMJ 1990;301:516–8.
- Prior JC, Vigna YM, Schechter MT, Burgess AE. Spinal bone loss and ovulatory disturbances. N Engl J Med 1990;323:1221–7.
- Glüer CC, Steiger P, Selvidge R, Elliesen-Kleiforth K, Hayashi C, Genant HK. Comparative assessment of dual-photon absorptiometry and dual-energy radiography. Radiology 1990;174:223–8.
- Frost HM. Bone mass and the ‘mechanostat’: a proposal. Anat Rec 1987;219:1–9.
- Seeman E, Wahner HW, Offord KP, Kumar R, Johnson WY, Riggs BL. Differential effect of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest 1982;69:1302–9.
- Emans SJ, Grace E, Hoffer FA, Gundberg C, Ravinkar V, Woods ER. Estrogen deficiency in adolescents and young adults: impact on bone mineral content and effects of estrogen replacement therapy. Obstet Gynecol 1990;76:585–92.
- Myburgh KH, Hutchins J, Fataar AB, Hough SF, Noakes TD. Low bone density is an etiologic factor for stress fractures in athletes. Ann Intern Med 1990;113:754–9.
- Williams SR, Frenchek B, Speroff T, Speroff L. A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement. Am J Obstet Gynecol 1990;162:438–46.
- Drinkwater BL, Nilson K, Ott S, Chesnut CH III. Bone mineral density after resumption of menses in amenorrheic athletes. JAMA 1986;256:380–2.
- Bone mineral density in young women with long-standing amenorrhea: Limited effect of hormone replacement therapy with ethinylestradiol and desogestrel
Volume 4, Issue 2 , pp 99-103
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Bone mineral density
- Hormone replacement therapy
- Industry Sectors